Donor cancer transmission in kidney transplantation: A systematic review

American Journal of Transplantation

Volumn 13, Issue 10, 2013, Pages 2645-2652

  Xiao, D ^a   Craig, J C ^a,b   Chapman, J R ^c   Dominguez Gil, B ^d   Tong, A ^a   Wong, G ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d ORGANIZACIÓN NACIONAL DE TRASPLANTES   (Spain)

Author keywords

Cancer transmission; donor cancer; kidney transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOMODULATING AGENT;

CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CANCER TRANSMISSION; CHORIOCARCINOMA; DISEASE TRANSMISSION; GRAFT RECIPIENT; HEALTH STATUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CANCER; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LUNG CANCER; LYMPHOMA; MELANOMA; METASTASIS; METASTATIC MELANOMA; MULTIMODALITY CANCER THERAPY; NEPHRECTOMY; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; TRANSPLANT SURGEON;

CANCER TRANSMISSION; DONOR CANCER; KIDNEY TRANSPLANTATION;

HUMANS; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; PROGNOSIS; SURVIVAL RATE; TISSUE DONORS;

EID: 84884901379     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12430     Document Type: Review

References (41)

1. Notify Group. NOTIFY. Exploring Vigilance Notification for Organs, Tissues and Cells. Bologna: Editrice compositori, 2011.
2. Buell JF, Beebe TM, Trofe J, et al. Donor transmitted malignancies. Ann Transplant 2004; 9: 53-56.
3. Fishman JA., Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
4. Penn I., Transmission of cancer with donor organs. Transplant Proc 1988; 20: 739-740.
5. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW., Deceased donors with a past history of malignancy: An Organ Procurement and Transplantation Network/United Network for Organ Sharing update. Transplantation 2007; 84: 272-274.
6. Armanios MY, Grossman SA, Yang SC, et al. Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: Case study, review of the literature. Neuro Oncol 2004; 6: 259-263.
7. Bajaj NS, Watt C, Hadjiliadis D, et al. Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int 2010; 23: e26-e31.
8. Kauffman HM, McBride MA, Delmonico FL., First report of the United Network for Organ Sharing Transplant Tumor Registry: Donors with a history of cancer. Transplantation 2000; 70: 1747-1751.
9. Nalesnik MA, Woodle ES, Dimaio JM, et al. Donor-transmitted malignancies in organ transplantation: Assessment of clinical risk. Am J Transplant 2011; 11: 1140-1147.
10. Nicol DL, Preston JM, Wall DR, et al. Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation. BJU Int 2008; 102: 188-192; discussion 92-93.
11. Brook NR, Gibbons N, Johnson DW, Nicol DL., Outcomes of transplants from patients with small renal tumours, live unrelated donors and dialysis wait-listed patients. Transpl Int 2010; 23: 476-483.
12. Musquera M, Pérez M, Peri L, et al. Kidneys from donors with incidental renal tumors: Should they be considered acceptable option for transplantation ? Transplantation 2013; 95: 1129-1133.
13. World Health Organisation. 2013. [20 March]. Available at: http://www.who.int/en/. Accessed March 20, 2013.
14. Nanni Costa A, Grossi P, Gianelli Castiglione A, Grigioni WF, Italian Transplant Research Network. Quality and safety in the Italian donor evaluation process. Transplantation 2008; 85: S52-S56.
15. SOHOV&S. Vigilance and surveillance of substances of human origin, Project 2013 (20 March 2013). Available at: http://www.sohovs.org/soho/. Accessed March 20, 2013.
16. European Framework for the Evaluation of Organ Transplants. 2013 (updated 14 July 2011, 20 April 2013). Available at: http://www.efretos.org/. Accessed March 20, 2013.
17. Nalesnik MA, Michael G., Organ transplantation from deceased with cancer: Is it safe ? Open Access Surg 2011; 4: 11-20.
18. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 2000; 283: 2008-2012.
19. Guidelines for reporting observational studies [updated 5 October 2012, 12 January 2012]. Available at: http://www.equator-network.org/resource-centre/ library-of-health-research-reporting/reporting-guidelines/observational-studies/ . Accessed January 14, 2013.
20. Ison MG, Hager J, Blumberg E, et al. Donor-derived disease transmission events in the United States: Data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009; 9: 1929-1935.
21. Notify Library: The Global Vigilance and Surveillance Database for Transplantation and Assisted Reproduction: WHO Collaborating Centre on Vigilance and Surveillance for Human Cells, Tissues and Organs, Centro Nazionale Trapianti; 2013. Available at: http://www.notifylibrary.org/. Accessed April 15, 2013.
22. Lucewicz A, Wong G, Lam VWT, et al. Management of primary symptomatic lymphocele after kidney transplantation: A systematic review. Transplantation 2011; 92: 663-673.
23. Kunisch-Hoppe M, Hoppe M, Bohle RM, et al. Metastatic RCC arising in a transplant kidney. Eur Radiol 1998; 8: 1441-1443.
24. Neipp M, Schwarz A, Pertschy S, Klempnauer J, Becker T., Accidental transplantation of a kidney with a cystic renal cell carcinoma following living donation: Management and 1 yr follow-up. Clin Transplant 2006; 20: 147-150.
25. Alexander JW, Zola JC., Expanding the donor pool: Use of marginal donors for solid organ transplantation. Clin Transplant 1996; 10: 1-19.
26. Cohen B, Smits JM, Haase B, Persijn G, Vanrenterghem Y, Frei U., Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 2005; 20: 34-41.
27. Pomfret EA, Sung RS, Allan J, Kinkhabwala M, Melancon JK, Roberts JP., Solving the organ shortage crisis: The 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant 2008; 8: 745-752.
28. Strauss DC, Thomas JM., Transmission of donor melanoma by organ transplantation. Lancet Oncol 2010; 11: 790-796.
29. Teng MWL, Swann JB, Koebel CM, Schreiber RD, Smyth MJ., Immune-mediated dormancy: An equilibrium with cancer. J Leukoc Biol 2008; 84: 988-993.
30. Nair BT, Bhat SH, Narayan UV, et al. Donate organs not malignancies: Postoperative small cell lung carcinoma in a marginal living kidney donor. Transplant Proc 2007; 39: 3477-3480.
31. Guide to safety and quality assurance for the transplantation of organs, tissues and cells. 4th ed. [20 December 2012]. Available at: http://www.edqm.eu/en/blood-organ-guides-1131.html. Accessed March 25, 2013.
32. Buell JF, Trofe J, Sethuraman G, et al. Donors with central nervous system malignancies: Are they truly safe ? Transplantation 2003; 76: 340-343.
33. Lotan D, Laufer J., Metastatic renal carcinoma in a pediatric recipient of an adult cadaveric donor kidney. Am J Kidney Dis 1995; 26: 960-962.
34. Mocelin AJ., Letter: Inadvertent transplant of a malignancy. Transplantation 1975; 19: 430.
35. Myron Kauffman H, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM., Transplant tumor registry: Donor related malignancies. Transplantation 2002; 74: 358-362.
36. Loren AW, Porter DL, Stadtmauer EA, Tsai DE., Post-transplant lymphoproliferative disorder: A review. Bone Marrow Transplant 2003; 31: 145-155.
37. Gassel AM, Westphal E, Hansmann ML, Leimenstoll G, Gassel HJ., Malignant lymphoma of donor origin after renal transplantation: A case report. Hum Pathol 1991; 22: 1291-1293.
38. Hjelle B, Evans-Holm M, Yen TS, Garovoy M, Guis M, Edman JC., A poorly differentiated lymphoma of donor origin in a renal allograft recipient. Transplantation 1989; 47: 945-948.
39. Schutt G, Engemann R, Gassel HJ, et al. Donor-transmitted non-Hodgkin's lymphoma after renal transplantation-A case report. Transplant Proc 1993; 25: 2131-2132.
40. Tong A, Chapman JR, Wong G, de Bruijn J, Craig JC., Screening and follow-up of living kidney donors: A systematic review of clinical practice guidelines. Transplantation 2011; 92: 962-972.
41. European Parliament C. Directive 2010/45/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality, safety of human organs intended for transplantation [Directive]. 2010 (20 April 2013). Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32010L0053:EN: NOT. Accessed May 20, 2013.